GKB Ophthalmics

{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.38",
    "chg": -1.42,
    "chgp": "-2.06%",
    "dir": -1,
    "prev_price": "68.80",
    "mcapval": "35.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "Healthcare Services",
    "ind_code": 31,
    "indexname": "India SENSEX",
    "isin": "INE265D01015",
    "curr_date": "May 22",
    "curr_time": "",
    "bse_nse_vol": "447 ",
    "exc_status": "Active",
    "traded_date": "May 22, 2026",
    "traded_date_str": "2026 05 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GKB Ophthalmics Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-sell-on-technical-improvements-despite-fundamental-challenges-4004482",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GKBOphthalmicsL_mojoScore_4004482.png",
        "date": "2026-05-22 08:13:14",
        "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 21 May 2026, driven primarily by a shift in technical indicators. While the company’s financial fundamentals remain weak, recent positive technical trends have prompted a reassessment of its near-term outlook. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change."
      },
      {
        "title": "GKB Ophthalmics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-is-rated-strong-sell-3989144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GKBOphthalmicsL_mojoScore_3989144.png",
        "date": "2026-05-13 10:11:11",
        "description": "GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Dec 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "GKB Ophthalmics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-is-rated-strong-sell-3969868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GKBOphthalmicsL_mojoScore_3969868.png",
        "date": "2026-04-30 10:11:00",
        "description": "GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "GKB Ophthalmics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-is-rated-strong-sell-3941374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GKBOphthalmicsL_mojoScore_3941374.png",
        "date": "2026-04-10 10:10:57",
        "description": "GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 Dec 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 74,
    "sid": "360373",
    "stock_news_url": "https://www.marketsmojo.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ende March 31 2026.",
      "datetime": "04-May-2026",
      "details": "GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the company for the qurter and year ended March 31 2026. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulation 2015 had been closed from April 01 2026 will now re-open after the completion of 48 hours from the date of submission of financial results to the Stock Exchange. This communication has been sent to all the Directors sand all the designated emplyoyees of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018",
      "datetime": "07-Apr-2026",
      "details": "Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 262018 issued by the securities and Exchange Board of India we hereby confirm that GKB Ophthalmics Limited is not a Large Corporate as defined in the said Circular and hence the said Circular is not applicable to us. Kindly take the above information on record.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026. Kindly acknowledge receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "27 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

GKB Ophthalmics Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges

2026-05-22 08:13:14

GKB Ophthalmics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 21 May 2026, driven primarily by a shift in technical indicators. While the company’s financial fundamentals remain weak, recent positive technical trends have prompted a reassessment of its near-term outlook. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.

Read full news article

GKB Ophthalmics Ltd is Rated Strong Sell

2026-05-13 10:11:11

GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Dec 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

GKB Ophthalmics Ltd is Rated Strong Sell

2026-04-30 10:11:00

GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

GKB Ophthalmics Ltd is Rated Strong Sell

2026-04-10 10:10:57

GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 Dec 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News